Morgan Stanley Assertio Holdings, Inc. Call Options Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ASRT
# of Institutions
100Shares Held
30.9MCall Options Held
1.17MPut Options Held
43.1K-
Nantahala Capital Management, LLC New Canaan, CT8.15MShares$6.93 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$3.73 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.99MShares$2.54 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.18 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.1MShares$936,0860.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $41M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...